XEROX HOLDINGS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME (UNAUDITED) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues
Total Revenues		$ 1,576	$ 1,578	$ 3,033	$ 3,080
Costs and Expenses
Research, development and engineering expenses		43	50	85	99
Selling, administrative and general expenses		368	393	746	790
Restructuring and related costs, net		10	12	9	51
Amortization of intangible assets		10	10	20	20
Divestitures		0	(3)	(4)	51
Other expenses, net		80	33	148	77
Total Costs and Expenses		1,636	1,553	3,160	3,205
(Loss) Income before Income Taxes		(60)	25	(127)	(125)
Income tax expense (benefit)		46	7	69	(30)
Net (Loss) Income		(106)	18	(196)	(95)
Less: Preferred stock dividends, net		(3)	(3)	(7)	(7)
Net (Loss) Income attributable to Common Shareholders		$ (109)	$ 15	$ (203)	$ (102)
Basic (Loss) Income per Share (in dollars per share)		$ (0.87)	$ 0.12	$ (1.62)	$ (0.83)
Diluted (Loss) Income per Share (in dollars per share)		$ (0.87)	$ 0.11	$ (1.62)	$ (0.83)
Sales
Revenues
Total Revenues		$ 665	$ 611	$ 1,222	$ 1,134
Costs and Expenses
Cost of sales/services, maintenance and rentals		480	387	862	727
Services, maintenance, rentals and other
Revenues
Total Revenues	[1]	911	967	1,811	1,946
Costs and Expenses
Cost of sales/services, maintenance and rentals	[1]	$ 645	$ 671	$ 1,294	$ 1,390

[1] In 2025, certain reclassifications were made within the Condensed Consolidated Statement of (Loss) Income to the prior periods in order to conform to the current period reporting. Refer to the Segments section of Note 1 - Basis of Presentation for additional information.